Cresco Labs (CRLBF) Notes Payables (2019 - 2025)

Cresco Labs' Notes Payables history runs 7 years deep, the most recent figure standing at $10.8 million for Q4 2025.

• Quarterly Notes Payables changed N/A year-over-year to $10.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $10.8 million (changed N/A YoY) and the FY2025 annual result came in at $10.8 million, changed N/A from the prior year.
• Notes Payables was $10.8 million for Q4 2025 at Cresco Labs, down from $22.3 million in the prior quarter.
• Across five years, Notes Payables topped out at $29.2 million in Q1 2022 and bottomed at $10.8 million in Q4 2025.
• A 5-year average of $19.0 million and a median of $19.9 million in 2021 frame the typical range for Notes Payables.
• Annual changes were most pronounced in 2021 — Notes Payables fell 23.13% — and 2022, when it climbed 4.24%.
• Cresco Labs' Notes Payables stood at $19.9 million in 2021, then jumped by 46.54% to $29.2 million in 2022, then sank by 59.53% to $11.8 million in 2023, then surged by 88.33% to $22.3 million in 2024, then sank by 51.54% to $10.8 million in 2025.
• Business Quant data shows CRLBF's Notes Payables at $10.8 million in Q4 2025, $22.3 million in Q3 2024, and $12.3 million in Q2 2024.